Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company KemPharm Inc.
DescriptionExtended release prodrug of quetiapine
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCentral nervous system (CNS) disorders
Indication DetailsTreat central nervous system (CNS) disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today